Investment
Features
FeesSafety
Academy
More
Pluang+

Jack Henry & Associates set to report Q2 earnings with $1.47 EPS forecast on $631.6M revenue, showing strong financial health.

Company Fundamentals
18 Aug 2026
Stuart Mooney
View Source
Bullish
pluang ai news

Jack Henry & Associates is expected to report Q2 earnings with an EPS of $1.47 and revenue of $631.6 million. Analysts note the company has a strong record of beating earnings estimates, with an average surprise of nearly 20% in recent quarters. Financially, the company remains healthy with a low debt-to-equity ratio of 0.04 and a current ratio of 1.74. Investors will closely watch the report released after market close on August 18, 2026, for insights into the company's performance and future outlook.

More News

Analysts raise Cheniere Energy price targets amid strong growth outlook for LNG sector

Analysts raise Cheniere Energy price targets amid strong growth outlook for LNG sector

Analysts have raised their price targets for Cheniere Energy, signaling confidence in the company's future growth. Argus increased its target to $330, suggesting a 20.33% upside from the current price of around $274. TD Cowen also raised its target t...

Analyst Insights
Bullish
47 minutes ago
KeyBanc and DA Davidson upgrade Duolingo stock, boosting shares 4.3% pre-market.

KeyBanc and DA Davidson upgrade Duolingo stock, boosting shares 4.3% pre-market.

KeyBanc and DA Davidson upgraded Duolingo's stock rating, citing positive sentiment and raising price targets to $137.11 and $160 respectively. This upgrade lifted Duolingo shares by 4.3% in pre-market trading to $135.71. Despite this optimism, most ...

Analyst Insights
Bullish
51 minutes ago
ReNew Energy beats Q1 FY2027 estimates with strong revenue and expanded capacity.

ReNew Energy beats Q1 FY2027 estimates with strong revenue and expanded capacity.

ReNew Energy Global exceeded analyst expectations in Q1 FY2027 by reporting EPS of $0.17 versus $0.12 estimated and revenue of $506.4 million, surpassing the $459.86 million forecast. The company expanded its renewable energy portfolio to about 20.5 ...

Company Fundamentals
Bullish
59 minutes ago
Argenx stock jumps after positive Phase 3 trial results for new autoimmune myositis treatment.

Argenx stock jumps after positive Phase 3 trial results for new autoimmune myositis treatment.

Argenx reported successful Phase 3 clinical trial results for its drug VYVGART Hytrulo, targeting autoimmune myositis, especially benefiting patients with IMNM who lack approved therapies. The trial met its primary endpoint with statistically signifi...

Analyst Insights
Bullish
1 hour ago
Morgan Stanley raises Targa Resources price target to $343 on strong Q2 and growth plans

Morgan Stanley raises Targa Resources price target to $343 on strong Q2 and growth plans

Morgan Stanley increased its price target for Targa Resources to $343, maintaining an Overweight rating due to the company's strong Q2 results and growth outlook. Targa Resources exceeded profit estimates with a 38% rise in adjusted EBITDA, driven by...

Analyst Insights
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App